A Study Involving Collection of Samples and Data From Sarcoma Patients Receiving Immunotherapy
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT06113315
- Status
- Enrolling By Invitation
Conditions
- Sarcoma
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
The researchers are doing this study to improve their knowledge about immunotherapy use and how effective it is as a treatment for people with sarcoma by collecting information from participants' medical records who have been treated with immune checkpoint blockade or T-cell receptor-based therapy.
Key Dates
- Start date
- Oct 27, 2023
- Status verified
- Oct 2025
- Primary completion
- Oct 31, 2028
- Completion
- Oct 31, 2028
Study Design
- Enrollment
- 250 participants (estimated)
Arms
- Arm: Treatment-naïve patients who have not received any ICB and/or ACT treatment at time of consentThis is an observational prospective cohort study of patients with sarcoma treated with immune checkpoint blockade (ICB; anti-PD-1, PD-L1, and/or CTLA-4) or adoptive cell therapy (ACT; tumor infiltrating lymphocytes and/or engineered T cell receptor therapy) at Memorial Sloan Kettering Cancer Center (MSK).
- Arm: Treatment-experienced patients who have already received ICB and/or ACT treatment at time of consentThis is an observational prospective cohort study of patients with sarcoma treated with immune checkpoint blockade (ICB; anti-PD-1, PD-L1, and/or CTLA-4) or adoptive cell therapy (ACT; tumor infiltrating lymphocytes and/or engineered T cell receptor therapy) at Memorial Sloan Kettering Cancer Center (MSK).
Primary Outcome Measure
prospectively collect and store blood [ Time Frame: up to 5 years ]
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | Basking Ridge | New Jersey | 07920 | - |
| Memorial Sloan Kettering Monmouth (All Protocol Activities) | Middletown | New Jersey | 07748 | - |
| Memorial Sloan Kettering Bergen (All Protocol Activities) | Montvale | New Jersey | 07645 | - |
| Memorial Sloan Kettering Cancer Center Suffolk- Commack (All Protocol Activities) | Commack | New York | 11725 | - |
| Memorial Sloan Kettering Westchester (All Protocol Activities) | Harrison | New York | 10604 | - |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | - |
| Memorial Sloan Kettering Nassau (All Protocol Activities) | Uniondale | New York | 11553 | - |
Find similar trials in Basking Ridge, NJ
By research site
Memorial Sloan Kettering Cancer Center (All Protocol Activities)· Basking Ridge, NJMemorial Sloan Kettering Monmouth (All Protocol Activities)· Middletown, NJMemorial Sloan Kettering Bergen (All Protocol Activities)· Montvale, NJMemorial Sloan Kettering Cancer Center Suffolk- Commack (All Protocol Activities)· Commack, NYMemorial Sloan Kettering Westchester (All Protocol Activities)· Harrison, NYMemorial Sloan Kettering Cancer Center· New York, NY
Related Studies
- Novel Biochemical and Molecular Determinants for Soft Tissue SarcomaRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological StudiesRecruiting · National Cancer Institute (NCI) · Washington D.C., District of Columbia
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic OncologyPHASE4 · Enrolling By Invitation · Massachusetts General Hospital · Los Angeles, California